(Press-News.org) Treatment with natalizumab in patients with multiple sclerosis (MS) appears linked with JC virus (JCV) infection, which can lead to a rare and often fatal demyelinating disease of the central nervous system called progressive multifocal leukoencephalopathy (PML) that destroys the myelin that protects nerve cells. The movement of cells with JC virus into the blood stream may provide researchers with a possible reason why patients with MS develop PML
Since natalizumab was reintroduced as a biologic therapy for MS in 2006, more than 440 cases of PML have been reported. Risk factors associated with development of PML include receiving 24 or more natalizumab infusions, receiving other immunosuppressive treatments and testing positive for JCV antibodies in a blood test.
The authors evaluated 49 patients with MS and 18 healthy volunteers by drawing blood samples and examining CD34+ cells from the bone marrow plus CD19+ and CD3+ cells. Among the 49 MS patients, 26 were beginning natalizumab therapy. For these patients, blood was drawn at baseline and again at approximately three-month intervals to 10 months.. Blood also was drawn on a single occasion from 23 patients with MS receiving natalizumab for more than two years and from the 18 healthy volunteers.
Of the 26 patients beginning natalizumab therapy, 50 percent had detectable JC virus DNA in at least one cell subtype at one or more measures. Among the 23 patients who received natalizumab treatment for two years, 10 patients (44 percent) had detectable viral DNA in one or more cell subtype, as did three of the 18 healthy volunteers (17 percent). Of the 49 total patients with MS, 15 (31 percent) were confirmed to have JCV in CD34+ cells and 12 of the 49 (24 percent) had it in CD19+ cells.
"We detected JCV DNA within the cell compartments of natalizumab-treated MS patients after treatment inception and after 24 months. The JCV DNA may harbor [live] in CD34+ cells in bone marrow that mobilize into the peripheral circulation at high concentrations. Cells with latent infection initiate differentiation to CD19+ cells that favor growth of JCV. Continued studies are needed to further investigate natalizumab treatments as the mechanism of PML."
INFORMATION:
(JAMA Neurol. Published online March 24, 2014. doi:10.1001/.jamaneurol.2014.63. Available pre-embargo to the media at http://media.jamanetwork.com.)
Author: Elliot M Frohman, M.D., Ph.D., of the University of Texas Southwestern Medical Center, Dallas, and colleagues.
Editor's Note: The authors made conflict of interest disclosures. The study was supported by the Division of Intramural Research funds (National Institute of Neurological and Communicative Diseases and National Institute of Allergy and Infectious Disease laboratories) and other sources. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Media Advisory: To contact corresponding author Elliot M. Frohman, M.D., Ph.D., call Remekca Owens at 214-648-3404 or email remekca.owens@utsouthwestern.edu. An author podcast will be available when the embargo lifts at http://bit.ly/LSa1MM.
Natalizumab treatment in patients with MS associated with JC virus infection
2014-03-25
ELSE PRESS RELEASES FROM THIS DATE:
Researchers issue state-of-the-state on genetic-based testing and treatment for breast cancer
2014-03-25
(Lebanon, NH, 03/24/2014)- Dartmouth researchers at its Norris Cotton Cancer Center have compiled a review of the role that information gathered through genetic testing plays in the diagnosis and treatment of breast cancer. The paper entitled "Personalized Therapy for Breast Cancer" was accepted on March 17, 2014, for publication in Clinical Genetics. The paper discusses targeted therapies, new biomarkers, and the quality of commercially available testing methods.
Genomic testing is changing the way breast cancer is diagnosed and treated. By examining a woman's genes ...
Excess weight at 1 year postpartum increases moms' risk for diabetes, heart problems
2014-03-25
TORONTO – 'Watch out for weight gain within a year of giving birth to prevent new risk of diabetes and cardiovascular disease.' That advice for women comes from a study published today in the journal Diabetes Care.
While it has long been believed that not losing 'baby weight' for several years after pregnancy carries long-term risks of diabetes and heart disease the research team at Mount Sinai Hospital, Toronto, aimed to test this theory by tracking risk factors and weight in the first 12 months after giving birth.
The team led by clinician-researcher Dr. Ravi ...
New drug raises potential for cancer treatment revolution
2014-03-25
A revolution in cancer treatment could soon be underway following a breakthrough that may lead to a dramatic improvement in cancer survival rates.
A new study at the University of Warwick, published today in the journal Angewandte Chemie International Edition, has developed a new drug that can manipulate the body's natural signalling and energy systems, allowing the body to attack and shut down cancerous cells.
Called ZL105, the drug is a compound based on the precious metal iridium. The study has found ZL105 could potentially replace currently used anticancer drugs, ...
Can virtual reality-based therapy help veterans overcome posttraumatic stress disorder?
2014-03-25
New Rochelle, NY, March 25, 2014—Posttraumatic stress disorder (PTSD) is common among military veterans and together with the often-related anxiety, depression, and psychological and emotional impairment can dramatically affect quality of life. A type of virtual reality (VR) treatment called Graded Exposure Therapy (GET) can improve PTSD symptoms and may also have a positive impact on these associated disorders, as described in an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is ...
Electronic medication alerts designed with provider in mind reduce prescribing errors
2014-03-25
INDIANAPOLIS -- Changing how medication alerts are presented in electronic medical records resulted in safer prescribing, increased efficiency and reduced workload for health care providers who placed drug orders in a study published online in the Journal of the American Medical Informatics Association.
"The VA electronic medical record system is one of the most widely used and respected EMR systems in the country," said Alissa L. Russ, Ph.D., a human factors engineer who led the study. "This EMR is used by providers at over 150 VA hospitals. We are looking at ways to ...
Pesticides make the life of earthworms miserable
2014-03-25
Pesticides have a direct impact on the physiology and behaviour of earthworms, a Danish/French research team reports after having studied earthworms that were exposed to pesticides over generations.
"We see that the worms have developed methods to detoxify themselves, so that they can live in soil sprayed with fungicide. They spend a lot of energy on detoxifying, and that comes with a cost: The worms do not reach the same size as other worms, and we see that there are fewer of them in sprayed soil. An explanation could be that they are less successful at reproducing, ...
RI Hospital: Number of patients admitted with antibiotic-resistant infections is rising
2014-03-25
PROVIDENCE, R.I. – The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published online in the journal Antimicrobial Resistance and Infection Control.
"Over the last several years, we've seen an increase in the number of bacteria -- many of which are forms of E. coli -- that are resistant to commonly administered antibiotics," said Leonard Mermel, D.O., medical director of the department of epidemiology and infection ...
Twenty-five percent of breast cancer survivors report financial decline due to treatment
2014-03-25
ANN ARBOR, Mich. — Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.
In addition, 12 percent reported that they still have medical debt from their treatment.
Financial decline varied significantly by race, with Spanish-speaking Latinas most likely to be impacted. Debt was reported more frequently in English-speaking Latinas and Blacks, the study found. Results appear in ...
Blood test may help predict whether a child will become obese
2014-03-25
Scientists have found that a simple blood test, which can read DNA, could be used to predict obesity levels in children.
Researchers at the Universities of Southampton, Exeter and Plymouth used the test to assess the levels of epigenetic switches in the PGC1a gene – a gene that regulates fat storage in the body.
Epigenetic switches take place through a chemical change called DNA methylation which controls how genes work and is set during early life.
The Southampton team found that the test, when carried out on children at five years old, differentiates between children ...
Kids' books featuring animals with human traits lead to less learning of the natural world
2014-03-25
TORONTO, ON – A new study by University of Toronto researchers has found that kids' books featuring animals with human characteristics not only lead to less factual learning but also influence children's reasoning about animals.
Researchers also found that young readers are more likely to attribute human behaviors and emotions to animals when exposed to books with anthropomorphized animals than books depicting animals realistically.
"Books that portray animals realistically lead to more learning and more accurate biological understanding," says lead author Patricia ...